This article is more than 5 years old. Information may no longer be current.

VIDEO: Study finds iStent inject safe, efficacious

Issue: January 2019 2019

Add topic to email alerts

Receive an email when new articles are posted on

Please provide your email address to receive an email when new articles are posted on .

Subscribe

Added to email alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

Back to Healio

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

Back to Healio

SAN ANTONIO – Bobby Saenz, OD, MS, FAAO, reported here at the American Academy of Optometry meeting that the iStent inject produced a greater than 20% reduction in diurnal IOP in a randomized, prospective trial.

“We can be confident that we can recommend the iStent inject for our mild to moderate glaucoma patients who are getting cataract surgery due to its safety profile and that it’s really efficacious,” he said.